Answers are grounded in this paper and cite their sources.
This study aimed to investigate the solid forms of the peptic ulcer agent rebamipide (RBM). Four RBM solvates, including dimethyl sulfoxide solvate (RBM/DMSO), dichloromethane solvate (RBM/CH2Cl2), hydrate (RBM/H2O), and hemiethanol hemihydrate, were prepared via solvent crystallization. Single crystals of RBM/DMSO and RBM/CH2Cl2 were successfully obtained at 4 °C. These solid forms were both monoclinic with the space group P21/c. Hirshfeld surface and 2D fingerprint plot analyses indicated that RBM/DMSO and RBM/CH2Cl2 showed similarities in hydrogen bonds but exhibited differences in subtle intermolecular interactions. RBM/CH2Cl2 transformed into a novel solid form (form 3) after solvent removal and transformed into another solid form (form 4) when heated at 220 °C. RBM/H2O was converted to form 5 after dehydration. Forms 3–5 were RBM polymorphs. The stability results indicated that RBM/H2O, form 3, and form 4 showed good stability at 40 °C and 75% relative humidity. Furthermore, the three solid forms displayed higher solubility than commercial RBM (form 1) in both water and phosphate buffer solution (PBS). Compared with form 1, RBM/H2O and form 4 showed a comparable and faster dissolution rate in water and PBS, respectively.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: